Posted On: 03/06/2015 10:07:05 AM
Post# of 7769
Re: celtics2014 #6609
Here are my 4th quarter predictions:
1. Main Ave: Compounding will regain a $5-5.5M per month revenue base. MAV's revenues are limited by the number of staff. Compounding revenues will only grow if SCRC increases MAV's staff & facility or expands the number of pharmacies filling prescriptions.
2. PIMD: PIMD is a jewel. With 16 States (and growing) along with better purchasing power (no maximums), PIMD will generating $2.5-2.9M per month. This is a very conservative projection of 20% growth each month.
3. Diabetic Program: I project a 30% monthly increase in patient enrollment which will generate 4th quarter revenues of $650K - $1M per month.
SCRC 4th Revenue Projection (based on MAV, DIA, & PIMD): $8.6M - $9.4M per month, or a $103M - $113 annual run rate.
PPS: By the end of December I will go out there and say $1.00 per share. The ride to December will be enjoyable for all of us.
1. Main Ave: Compounding will regain a $5-5.5M per month revenue base. MAV's revenues are limited by the number of staff. Compounding revenues will only grow if SCRC increases MAV's staff & facility or expands the number of pharmacies filling prescriptions.
2. PIMD: PIMD is a jewel. With 16 States (and growing) along with better purchasing power (no maximums), PIMD will generating $2.5-2.9M per month. This is a very conservative projection of 20% growth each month.
3. Diabetic Program: I project a 30% monthly increase in patient enrollment which will generate 4th quarter revenues of $650K - $1M per month.
SCRC 4th Revenue Projection (based on MAV, DIA, & PIMD): $8.6M - $9.4M per month, or a $103M - $113 annual run rate.
PPS: By the end of December I will go out there and say $1.00 per share. The ride to December will be enjoyable for all of us.
(0)
(0)
